Back
Madrigal Pharmaceuticals Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
46
MDGL
Madrigal Pharmaceuticals
Last Price:
$291.14
Seasonality Move:
-7.12%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MDGL is experiencing slight selling pressure.
Madrigal Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 294.35 | Sell |
| 20-day SMA: | 307.94 | Sell |
| 50-day SMA: | 319.52 | Sell |
| 200-day SMA: | 292.14 | Sell |
| 8-day EMA: | 295.36 | Sell |
| 20-day EMA: | 304.41 | Sell |
| 50-day EMA: | 313.82 | Sell |
| 200-day EMA: | 297.16 | Sell |
Madrigal Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -8.32 | Sell |
| Relative Strength Index (14 RSI): | 40.85 | Sell |
| Chaikin Money Flow: | -22001 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (293.93 - 324.37) | Sell |
| Bollinger Bands (100): | (302.49 - 339.37) | Sell |
Madrigal Pharmaceuticals Technical Analysis
| May 5 | May 6 | May 7 | May 8 | May 9 | May 12 | May 13 | May 14 | May 15 | May 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 05 | 06 | 07 | 08 | 09 | 12 | 13 | 14 | 15 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Madrigal Pharmaceuticals Stock
Is Madrigal Pharmaceuticals Stock a Buy?
-
Madrigal Pharmaceuticals share price is 290.96 while MDGL 8-day simple moving average is 294.35, which is a Sell signal.
-
The stock price of MDGL is 290.96 while Madrigal Pharmaceuticals 20-day SMA is 307.94, which makes it a Sell.
-
Madrigal Pharmaceuticals 50-day simple moving average is 319.52 while MDGL share price is 290.96, making it a Sell technically.
-
MDGL stock price is 290.96 and Madrigal Pharmaceuticals 200-day simple moving average is 292.14, creating a Sell signal.
MDGL Technical Analysis vs Fundamental Analysis
Sell
46
Madrigal Pharmaceuticals (MDGL)
is a Sell
Is Madrigal Pharmaceuticals a Buy or a Sell?
-
Madrigal Pharmaceuticals stock is rated a SellThe current Madrigal Pharmaceuticals [MDGL] share price is $290.96. The Score for MDGL is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
Madrigal Pharmaceuticals Stock Info
Market Cap:
6.5B
Price in USD:
290.96
Share Volume:
293.3K
Madrigal Pharmaceuticals 52-Week Range
52-Week High:
377.46
52-Week Low:
200.63
Sell
46
Madrigal Pharmaceuticals (MDGL)
is a Sell
Madrigal Pharmaceuticals Share Price Forecast
-
What is the Madrigal Pharmaceuticals stock price today?The Madrigal Pharmaceuticals stock price is 290.96 USD today.
-
Will MDGL stock go up or go down?Madrigal Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators
-
Is Madrigal Pharmaceuticals overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Madrigal Pharmaceuticals is overvalued.
Is Madrigal Pharmaceuticals Stock a Buy?
-
Madrigal Pharmaceuticals share price is 290.96 while MDGL 8-day exponential moving average is 295.36, which is a Sell signal.
-
The stock price of MDGL is 290.96 while Madrigal Pharmaceuticals 20-day EMA is 304.41, which makes it a Sell.
-
Madrigal Pharmaceuticals 50-day exponential moving average is 313.82 while MDGL share price is 290.96, making it a Sell technically.
-
MDGL stock price is 290.96 and Madrigal Pharmaceuticals 200-day simple moving average is 297.16, creating a Sell signal.
Fundamental Analysis of Madrigal Pharmaceuticals
Is Madrigal Pharmaceuticals a good investment?
-
Analysts estimate an earnings increase this quarter of $3.44 per share, an increase next quarter of $1.75 per share, an increase this year of $10.92 per share, and an increase next year of $12.76 per share.
Technical Analysis of Madrigal Pharmaceuticals
Should I short Madrigal Pharmaceuticals stock?
-
MDGL Moving Average Covergence Divergence (MACD) indicator is -8.32, suggesting Madrigal Pharmaceuticals is a Sell
-
Madrigal Pharmaceuticals Relative Strength Index (RSI) is 40.85, which suggest Madrigal Pharmaceuticals is oversold
-
The Bollinger Bands (25) for Madrigal Pharmaceuticals is (293.93 - 324.37), which suggest Madrigal Pharmaceuticals is a Sell
-
The Bollinger Bands (100) for Madrigal Pharmaceuticals is (302.49 - 339.37), which suggest Madrigal Pharmaceuticals is a Sell
* Madrigal Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.